236 related articles for article (PubMed ID: 26039379)
1. Reversal of overdose on fentanyl being illicitly sold as heroin with naloxone nasal spray: A case report.
Fareed A; Buchanan-Cummings AM; Crampton K; Grant A; Drexler K
Am J Addict; 2015 Aug; 24(5):388-90. PubMed ID: 26039379
[TBL] [Abstract][Full Text] [Related]
2. Intravenous use of intranasal naloxone: A case of overdose reversal.
Das S; Shah N; Ghadiali M
Subst Abus; 2017; 38(1):18-21. PubMed ID: 27925864
[TBL] [Abstract][Full Text] [Related]
3. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
[TBL] [Abstract][Full Text] [Related]
4. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
Fairbairn N; Coffin PO; Walley AY
Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
[TBL] [Abstract][Full Text] [Related]
5. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
Kim HK; Connors NJ; Mazer-Amirshahi ME
Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357
[TBL] [Abstract][Full Text] [Related]
6. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
[TBL] [Abstract][Full Text] [Related]
7. Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a Veterans Affairs Medical Center.
Pauly JB; Vartan CM; Brooks AT
Subst Abus; 2018; 39(2):206-210. PubMed ID: 29565760
[TBL] [Abstract][Full Text] [Related]
8. Overdose education and naloxone distribution for veterans with opioid use disorder: Results from a pilot initiative.
Chang G; Davids M; Kershaw A
J Addict Dis; 2017; 36(4):217-221. PubMed ID: 28548574
[TBL] [Abstract][Full Text] [Related]
9. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
[TBL] [Abstract][Full Text] [Related]
10. Naloxone (Narcan) nasal spray for opioid overdose.
Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
[No Abstract] [Full Text] [Related]
11. Patient perceptions of higher-dose naloxone nasal spray for opioid overdose.
Strickland JC; Marks KR; Smith KE; Ellis JD; Hobelmann JG; Huhn AS
Int J Drug Policy; 2022 Aug; 106():103751. PubMed ID: 35636070
[TBL] [Abstract][Full Text] [Related]
12. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C
Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643
[TBL] [Abstract][Full Text] [Related]
13. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
Carroll JJ; Marshall BDL; Rich JD; Green TC
Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
[TBL] [Abstract][Full Text] [Related]
14. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data.
Mahonski SG; Leonard JB; Gatz JD; Seung H; Haas EE; Kim HK
Clin Toxicol (Phila); 2020 Feb; 58(2):117-123. PubMed ID: 31092050
[No Abstract] [Full Text] [Related]
15. Fentanyl analogue overdose: Key lessons in management in the synthetic opioid age.
Raheemullah A; Andruska N
J Opioid Manag; 2019; 15(5):428-432. PubMed ID: 31849033
[TBL] [Abstract][Full Text] [Related]
16. Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
Winston I; McDonald R; Tas B; Strang J
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370638
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities.
Coffin PO; Sullivan SD
J Med Econ; 2013 Aug; 16(8):1051-60. PubMed ID: 23730942
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of concentrated naloxone nasal spray over first 30 minutes post-dosing: analysis of suitability for opioid overdose reversal.
Mundin G; McDonald R; Smith K; Harris S; Strang J
Addiction; 2017 Sep; 112(9):1647-1652. PubMed ID: 28430384
[TBL] [Abstract][Full Text] [Related]
19. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
[TBL] [Abstract][Full Text] [Related]
20. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
